Astrantus’s Johnson & Johnson JNJ Stock Holding History

Astrantus’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$479K	Hold	2,700	–	–	0.81%	7
2021 Q4	$462K	Buy	+2,700	New	+$442K	0.35%	119

Other funds holding JNJ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Astrantus's JNJ Position: Q1 2022 in Review

Astrantus held its Johnson & Johnson (JNJ) position steady in Q1 2022 at 2,700 shares worth $479K. The position accounts for 0.81% of the portfolio, ranked #7.

Astrantus first reported a position in JNJ in Q4 2021 and has held it in 2 quarters since. 3,676 funds tracked by Wall St. Rank hold JNJ as of Q1 2022.

Astrantus held 2,700 shares of Johnson & Johnson worth $479K as of Q1 2022.
Astrantus left its Johnson & Johnson share count unchanged in Q1 2022.
Johnson & Johnson made up 0.81% of Astrantus's portfolio in Q1 2022, its #7 holding.
Astrantus first reported a position in Johnson & Johnson in Q4 2021 and has held it in 2 quarters since.
3,676 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2022.

Based on Astrantus's 13F filing for Q1 2022, filed 11 May 2022.